A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease

Conditions:   Sickle Cell Disease;   Sickle Cell Nephropathy Intervention:   Drug: Voxelotor Sponsors:   University of Illinois at Chicago;   Global Blood Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials